Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2023 | 3 |
2024 | 1 |
Search Results
4 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Increased Actin Binding Is a Shared Molecular Consequence of Numerous SCA5 Mutations in β-III-Spectrin.
Cells. 2023 Aug 19;12(16):2100. doi: 10.3390/cells12162100.
Cells. 2023.
PMID: 37626910
Free PMC article.
Early-phase drug discovery of β-III-spectrin actin-binding modulators for treatment of spinocerebellar ataxia type 5.
Guhathakurta P, Rebbeck RT, Denha SA, Keller AR, Carter AL, Atang AE, Svensson B, Thomas DD, Hays TS, Avery AW.
Guhathakurta P, et al. Among authors: keller ar.
J Biol Chem. 2023 Mar;299(3):102956. doi: 10.1016/j.jbc.2023.102956. Epub 2023 Jan 31.
J Biol Chem. 2023.
PMID: 36731793
Free PMC article.
Item in Clipboard
Nanobody-Mediated Dualsteric Engagement of the Angiotensin Receptor Broadens Biased Ligand Pharmacology.
Braga Emidio N, Small BM, Keller AR, Cheloha RW, Wingler LM.
Braga Emidio N, et al. Among authors: keller ar.
Mol Pharmacol. 2024 Feb 15;105(3):260-271. doi: 10.1124/molpharm.123.000797.
Mol Pharmacol. 2024.
PMID: 38164609
Free PMC article.
Item in Clipboard
Increased actin binding is a shared molecular consequence of numerous spinocerebellar ataxia mutations in β-III-spectrin.
Atang AE, Keller AR, Denha SA, Avery AW.
Atang AE, et al. Among authors: keller ar.
bioRxiv [Preprint]. 2023 Apr 10:2023.02.20.529285. doi: 10.1101/2023.02.20.529285.
bioRxiv. 2023.
PMID: 36865188
Free PMC article.
Updated.
Preprint.
Item in Clipboard
Cite
Cite